FDA Approved: DEXTROAMPHETAMINE SULFATE EXTENDED-RELEASE — Supplemental Application (SpecGx LLC)

View source ↗

Summary

FDA approves a supplemental application from SpecGx LLC for a dextroamphetamine sulfate extended-release product (generic).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Dextroamphetamine Sulfate Extended-Release (Dextroamphetamine sulfate)

Snippet

SUPPL AP for DEXTROAMPHETAMINE SULFATE EXTENDED-RELEASE (DEXTROAMPHETAMINE SULFATE)